Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2
Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.
2-Oct-2023 4:05 PM EDT
Add to Favorites